Linking indoor air and pharmacokinetic models to assess tetrachloroethylene risk.
Physiologically based pharmacokinetic (PBPK) models describing the uptake, metabolism, and excretion of xenobiotic compounds are now proposed for use in regulatory health-risk assessments. In this study we investigate the extent of PCE metabolism arising from domestic respiratory exposure to tetrachloroethylene (PCE) from ground water, as predicted using a PBPK model. Indoor exposure patterns we use as input to the PBPK model are realistic ones generated from a three-compartment model describing volatilization of PCE from domestic water into household air. Values we use for the metabolic parameters of the PBPK model are estimated from data on urinary metabolites in workers exposed to PCE. It is shown that for respiratory PCE exposure due to typical levels of PCE in ground water, use of time-weighted average air concentrations with a steady-state PBPK model yields estimates of total metabolized PCE similar to those obtained using completely dynamic modeling, despite considerable uncertainty in key exposure- and metabolic-model parameters. These findings suggest that, for PCE, risk estimation taking pharmacokinetics into account may be accomplished using a simple analytic approach.
Bogen
K T
KT
Environmental Sciences Division, Lawrence Livermore National Laboratory, Livermore, California 94550.
McKone
T E
TE
D000393:Air Pollutants / Q000009:adverse effects*; D000818:Animals; D005618:Fresh Water; D006798:Housing; D006801:Humans; D008657:Metabolic Clearance Rate; D008954:Models, Biological; D012307:Risk Factors; D013750:Tetrachloroethylene / Q000009:adverse effects / Q000493:pharmacokinetics*; D014835:Volatilization; D014877:Water Pollution, Chemical
D000393:Air Pollutants; D013750:Tetrachloroethylene